Preclinical Evaluation of the PI3K/Akt/mTOR Pathway in Animal Models of Multiple Sclerosis

Thumbnail
View/ Open

Show full item record

Author
McCubrey, James A.
URI
http://hdl.handle.net/10342/9647
Subject
 PI3K/Akt/mTOR pathway; animal models; multiple sclerosis 
Date
2018-01-03
Citation:
APA:
McCubrey, James A.. (January 2018). Preclinical Evaluation of the PI3K/Akt/mTOR Pathway in Animal Models of Multiple Sclerosis. Oncotarget, (9:9), p.8263-8277. Retrieved from http://hdl.handle.net/10342/9647

Display/Hide MLA, Chicago and APA citation formats.

MLA:
McCubrey, James A.. "Preclinical Evaluation of the PI3K/Akt/mTOR Pathway in Animal Models of Multiple Sclerosis". Oncotarget. 9:9. (8263-8277.), January 2018. May 24, 2022. http://hdl.handle.net/10342/9647.
Chicago:
McCubrey, James A., "Preclinical Evaluation of the PI3K/Akt/mTOR Pathway in Animal Models of Multiple Sclerosis," Oncotarget 9, no. 9 (January 2018), http://hdl.handle.net/10342/9647 (accessed May 24, 2022).
AMA:
McCubrey, James A.. Preclinical Evaluation of the PI3K/Akt/mTOR Pathway in Animal Models of Multiple Sclerosis. Oncotarget. January 2018; 9(9) 8263-8277. http://hdl.handle.net/10342/9647. Accessed May 24, 2022.
Collections